We are setting new standards
for the microbiome

Our vision is to propel our industry forward by fostering microbiome research on every level.

The BioCollective system produces superior samples, generates the highest quality-validating data, models the dynamics of microbiome structure and function and makes microbiome research more comparable and repeatable. Learn more about what we do.

Your results are only as good as your samples 

The BioCollector™ is the first and only patented collector for quality whole stool samples.

Our ick-free BioCollector Kit  has been used by Harvard’s Dana-Farber Cancer Institute, The University of Chicago, and Axial Biotherapeutics. The BioCollector™ Kit and process provides quality, homogeneous samples for use in multi-omic analysis — from genomics to metabolomics to isolation and culturing.

Setting higher standards

Leveraging our expertise in whole stool collection and homogenization, supported by an NIH SBIR grant, we developed the first whole stool reference materials in collaboration with Janssen's Mosaic™ Challenge,  National Institute of Standards and Technology and Zymo Research. The BioCollective has now developed a line of positive, negative, and spiked controls, called TruMatrix, to improve data reproducibility and elevate microbiome research.

The details are in the data

The BioCollective holds the keys to health and disease in our fecal sample bank. We believe answers lie in the depth and scope of microbiome data. Our fecal sample bank contains population samples and data across age, health, disease, lifestyle, and environment. These samples are homogenized and fully characterized for multi-omic research that can span wide and varied pipelines. 

jack _research 01.jpg
Predicting a new outcome

The BioCollective utilized its whole genome approach and expertise to develop complex computational microbiome modeling. Bioflux™ Metabolic Model connects the dots to determine how various organisms influence the structure and function of microbial communities.

This system is ideal for new product development, existing product analysis and optimization, and strain evaluation.

I understood Parkinson’s as a systemic problem; these are systemic conditions and require
that same systems approach from my business career to fully understand what’s going on.
So, I started applying my systems thinking to the problem.

Martha Carlin

MicrobiomeTimes / Read Full Article




Before we can
make correlations of
microorganisms with a condition,
we need to know that
the microbiome we have
is reflective of reality.

Dr. Raul Cano

Nature / Read Full Article





American Gut:
an Open Platform
for Citizen Science
Microbiome Research.

Dr. Naseer Sangwan
PubMed / Read Full Article





Learn more about
The BioCollective.
Select one

Thanks for submitting!